Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
FSCN3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PIANP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BLOC1S6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATM - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CEP41 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CPS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCDC171 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC400748 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
SHB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TCF20 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00518 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC401068 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors
MYNN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ELOVL6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LAMA2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GAB3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MEDAG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on